Dr Reddys Laboratories (RDY) Change in Account Payables (2009)
Dr Reddys Laboratories (RDY) posted quarterly Change in Account Payables of -$32.0 million for Q4 2009, down 557.14% quarter-over-quarter from $7.0 million in Q3 2009.
Dr Reddys Laboratories (RDY) Change in Account Payables (2009) Analysis & Trends
Dr Reddys Laboratories' Change in Account Payables history runs 1 years deep, the most recent figure standing at -$32.0 million for Q4 2009.
- In Q4 2009, Change in Account Payables changed N/A year-over-year to -$32.0 million; the TTM figure through Dec 2009 stood at -$30.9 million (changed N/A YoY), while the FY2026 annual figure was $30.0 million, up 650.0% from the prior year.
- Change in Account Payables for Q4 2009 stood at -$32.0 million, down from $7.0 million in the prior quarter.
- The five-year high for Change in Account Payables was $22.0 million in Q2 2009, with the low at -$32.0 million in Q4 2009.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.05 Bn | 43.08 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.39 Bn | 39.74 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | -53.00 Mn |
| 4 | Takeda Pharmaceutical | 28.78 Bn | 22.99 Bn | 5.10 Bn | -143.74 Mn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | -21.20 Mn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.92 Bn | 11.39 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 9.99 Bn | - | - |
| 10 | Alkermes | 8.17 Bn | 7.51 Bn | 397.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2009 | -32.00 Mn |
| Dec 31, 2009 | -32.00 Mn |
| Sep 30, 2009 | 7.00 Mn |
| Sep 30, 2009 | 7.00 Mn |
| Jun 30, 2009 | 22.00 Mn |
| Jun 30, 2009 | 22.00 Mn |